Biolase Inc
BIOL
Get informed when a big investor buys or sells
+ FollowMarket Cap$731.94K
Close$
$1.53
7551.5% upside
Current Fair Value
7551.5% upsideUndervalued by 7551.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $731,942.00 |
|---|---|
| Enterprise Value | $18.59 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-16.14 |
| Beta | 0.68 |
| Outstanding Shares | 36,083,000 |
Return
| Return on Equity | 306.81% |
|---|---|
| Return on Assets | -58.87% |
| Return on Invested Capital | 391.43% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.02 |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | 0.4 |
| Enterprise Value to EBIT | -1.31 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.15 |
| Debt to Equity | -4.08 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biolase Inc
CEO: Todd Norbe